Tislelizumab Combined With Chemotherapy or Radiotherapy in the Treatment of Advanced or Recurrent Metastatic Elderly Esophageal Cancer
Clinical trial NCT05628610 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05628610
- Sponsor
- Fujian Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-30
- Primary completion
- 2026-09-30
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.